Unique sequences represent the exciting area in drug research. Such short strings of building residues offer remarkable potential for targeting intractable processes involved in multiple diseases. Initial studies suggest they can provide specific interaction and show desirable bioavailability features, opening paths to innovative treatments. Ongoin